We provide you with 20 years of free, institutional-grade data for VBIV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VBIV. Explore the full financial landscape of VBIV stock.
| Reported Date | CIK | Ticker | Type |
|---|
VBI Vaccines Inc(NASDAQ:VBIV) 
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate ...
Website: http://www.vbivaccines.com
Founded: 1965
Full Time Employees: 123
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VBIV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.